Drug intelligence / Profile preview

allogeneic adipose tissue-derived mesenchymal stem cells

Development stage
Phase 2
Lead developer
AbelZeta, Inc.
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intraarticular, Intravenous, Local Implantation
01

Overview

Allogeneic adipose tissue-derived mesenchymal stem cells (allogeneic AD-MSCs or ADSCs) are multipotent stromal cells isolated from the adipose (fat) tissue of healthy donors and administered to unrelated recipients. These cells possess high regenerative potential and immunomodulatory properties, making them attractive for a range of therapeutic applications. Allogeneic AD-MSCs can differentiate into various cell types including osteoblasts, chondrocytes, and adipocytes. Their primary mechanisms include modulation of immune responses and promotion of tissue repair through paracrine signaling and direct differentiation. They have been investigated in clinical trials for conditions such as knee osteoarthritis, bone defects, wound healing, cardiovascular diseases, autoimmune disorders, and other indications where regeneration or immune modulation is needed[1][4][5]. Unlike autologous therapies (from the same patient), these products are derived from donor fat tissue—enabling off-the-shelf use.

Other names
allogeneic adipose-derived mesenchymal stromal cellsallogeneic AD-MSCsallogeneic ADSCs

Beyond the preview

Go deeper on allogeneic adipose tissue-derived mesenchymal stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic adipose tissue-derived mesenchymal stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call